{
  "subset": "contraindication",
  "disease": "Neonatal cholestasis",
  "relation": "contraindication",
  "gold_drugs": [
    "20% intravenous emulsion + intralipid",
    "4-phenylbutyrate",
    "[14c]-a4250 capsule",
    "a4250",
    "cholic acids",
    "clinolipid",
    "crc",
    "intralipid",
    "livmarli",
    "lum001",
    "magnesium",
    "magnesium gluconate",
    "maralixibat",
    "meropenem injection",
    "n-acetylcysteine",
    "odevixibat",
    "omegaven",
    "questran",
    "sincalide",
    "smoflipid",
    "smoflipid 20% lipid emulsion for injection",
    "sulperazon",
    "tak-625",
    "teicoplanin",
    "ursodiol"
  ],
  "seeds_initial": [
    "Ursodiol",
    "Rifampicin",
    "Cholestyramine",
    "Phenobarbital",
    "Chloramphenicol",
    "Ampicillin",
    "Nafcillin",
    "Tetracycline",
    "Ceftriaxone",
    "Erythromycin",
    "Sulfonamides",
    "Ibuprofen"
  ],
  "seed_history": [
    [
      "Ursodiol",
      "Rifampicin",
      "Cholestyramine",
      "Phenobarbital",
      "Chloramphenicol",
      "Ampicillin",
      "Nafcillin",
      "Tetracycline",
      "Ceftriaxone",
      "Erythromycin",
      "Sulfonamides",
      "Ibuprofen"
    ],
    [
      "Cholestyramine",
      "N-acetylcysteine",
      "Ursodeoxycholic acid",
      "Rifampicin",
      "Bile acid sequestrants",
      "Amiodarone",
      "Clarithromycin",
      "Azithromycin",
      "Sildenafil",
      "Lactulose",
      "Metronidazole",
      "Phenobarbital"
    ],
    [
      "Cholestyramine",
      "Amiodarone",
      "Fenofibrate",
      "Danazol",
      "Erythromycin",
      "Methotrexate",
      "Niaspan",
      "Loperamide",
      "Rifampin",
      "St. John's Wort",
      "Tetracycline",
      "Ursodiol"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_cholestyramine",
          "name": "Cholestyramine"
        },
        "score": 0.66,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "药物作用于胆汁酸转运体",
          "可能存在不良反应影响肝胆功能"
        ],
        "caveats": [
          "需关注潜在的胆汁淤积风险"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_amiodarone",
          "name": "Amiodarone"
        },
        "score": 0.64,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "对胆汁酸代谢有已知影响",
          "存在肝功能相关风险"
        ],
        "caveats": [
          "需关注肝毒性风险"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "score": 0.62,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "影响胆汁酸代谢",
          "有肝功能不良反应风险"
        ],
        "caveats": [
          "需审慎使用并监控肝功能"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_danazol",
          "name": "Danazol"
        },
        "score": 0.6,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "可能影响肝脏功能",
          "存在副作用风险"
        ],
        "caveats": [
          "应重视潜在的负面影响"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_erythromycin",
          "name": "Erythromycin"
        },
        "score": 0.58,
        "graph_snapshot_ref": "GE_H5_round4",
        "key_assumptions": [
          "可能干扰胆道功能",
          "有风险指向"
        ],
        "caveats": [
          "需警惕胆道功能影响"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target→Phenotype",
          "reason": "对于胆汁酸运输及其与新生儿胆汁淤积症的关联存在明确证据"
        }
      ],
      "remaining_gaps": [
        "仍需进一步验证各药物对新生儿胆汁淤积症的具体影响"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that are contraindicated or could worsen the rare disease 'Neonatal cholestasis'. Return only names.\n\n# Prior guidance for Explorer:\n- 以新生儿胆汁淤积患者为目标，优先开发与此相关的药物特性。\n\n# Heuristics:\n- When 考虑新生儿胆汁淤积的治疗: then 探讨药物相关风险与获益之间的权衡。\n- When 药物可能引发不良反应: then 寻找临床数据支持与剂量调整的可能性。"
}